Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-19T11:19:21.774Z Has data issue: false hasContentIssue false
  • English
  • Français

Recombinant Reflections

Published online by Cambridge University Press:  17 May 2016

Stanley S. Robin  and
Gerald E. Markle
Get access

Extract

One of the expectations of science, from both substantive and network perspectives, is its cumulative nature. It is a strong hope that scientific research and analysis promote an extension of knowledge as a function of critique and as a stimulus for extension. We are pleased that the comments of Curd, Duster, Lappé, and Mazur help us (and, we hope, others) better understand and appreciate our case study.

Type
Articles and Commentaries
Information
Politics and the Life Sciences , Volume 6 , Issue 1 , August 1987 , pp. 24 - 26
Copyright
Copyright © Association for Politics and the Life Sciences 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, W. F. (1984). “Prospects for Human Gene Therapy.” Science 226: 401–409.CrossRefGoogle ScholarPubMed
Anderson, W. F., and Fletcher, J. C. (1980). “Gene Therapy in Human Beings: When Is It Ethical to Begin?” The New England Journal of Medicine 303: 1293–1297.CrossRefGoogle ScholarPubMed
Axel, R. (1982). Personal interview, February 12.CrossRefGoogle Scholar
Barber, A. A. (1981). Personal interview, October 10.Google Scholar
Barber, B., Lolly, J. J., Makarushka, J. L., and Sullivan, D. (1973). Research on Human Subjects: Problems of Social Control in Medical Experimentation. New York: Russell Sage Foundation.Google Scholar
Bernard, C. (1865). An Introduction to the Study of Experimental Medicine. New ed.1949. Trans. byGreen, H. C.New York: Henry Schuman, Inc., p. 212.Google Scholar
Blank, R. H. (1981). The Political Implications of Human Genetic Technology. Boulder, Colo.: Westview Press.Google Scholar
Blaug, M. (1980). “Kuhn versus Lakatos, or Paradigms versus Research Programmes in the History of Economics.” In Gutting, G. (ed.), Paradigms and Revolutions. Notre Dame, Ind.: Notre Dame University Press, pp. 137–159.Google Scholar
Blume, S. S. (1979). Perspectives in the Sociology of Science. New York: Wiley.Google Scholar
Brody, J. E. (1975). “Genetic Aid Test Fails in Test on Humans.” New York Times March: 30.Google Scholar
Capron, A. M. (1984). “Human Genetic Engineering.” Technology in Society 6: 23–35.CrossRefGoogle Scholar
Cline, M. J. (1981). Personal interview, June 15.CrossRefGoogle Scholar
Cline, M. J., and Mercola, K. E. (1980). “The Potentials of Inserting New Genetic Information.” The New England Journal of Medicine 303: 1297–1300.Google Scholar
Friedmann, T., and Roblin, R. (1972). “Gene Therapy for Human Genetic Disease.” Science 175: 949–955.CrossRefGoogle ScholarPubMed
Fujimura, J. (1986). Bandwagons in Science: Doable Problems and Transportable Packages as Factors in the Development of the Molecular Genetic Bandwagon in Cancer Research. Unpublished , University of California, Berkeley.Google Scholar
Goggin, M. L. (1984). “The Life Sciences and the Public: Is Science Too Important to be Left to the Scientists?” Politics and the Life Sciences 3: 28–40.CrossRefGoogle Scholar
Goodell, R. (1980). “The Gene Craze.” Columbia Journalism Review Nov-Dec: 41–51.Google Scholar
Goodfield, J. (1981). Science and the Media. Washington, D. C.: American Association for the Advancement of Science, pp. 43–51.Google Scholar
Jacobs, P. (1980). “Pioneer Genetic Implants Revealed.” Los Angeles Times, October 8.Google Scholar
Judson, H. F. (1979). The Eighth Day of Creation. New York: Simon and Schuster.Google Scholar
Kolata, G. (1981). “Thalassemias: Models of Genetic Diseases.” Science 210: 300–302.CrossRefGoogle Scholar
Kolata, G. (1984). “Gene Therapy Method Shows Promise.” Science 223: 1376–1379.CrossRefGoogle ScholarPubMed
Krimsky, S., and Ozonoff, D. (1979). “Recombinant DNA Research: The Scope and Limits of Regulation.” American Journal of Public Health 69: 1252–1259.CrossRefGoogle ScholarPubMed
Kuhn, T. (1962). The Structure of Scientific Revolutions. Chicago: University of Chicago Press.Google Scholar
Lakatos, I., and Musgrave, A., eds. (1970). Criticism and the Growth of Knowledge. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
Maniatus, T. (1982). Personal interview, February 8.Google Scholar
Markle, G., and Robin, S. (1985). “Biotechnology and the Social Reconstruction of Molecular Biology.” Science, Technology and Human Values 10 (1): 70–79.CrossRefGoogle ScholarPubMed
Marx, J. L. (1986). “Gene Therapy—So Near and Yet So Far.” Science 232: 824–25.Google ScholarPubMed
Mazur, A. (1981). The Dynamics of Technical Controversy. Washington, D. C.: Communications Press.Google Scholar
Nelkin, D. (1979). Controversy: Politics of Technical Decisions. Beverly Hills: Sage.Google Scholar
Petersen, J. C., and Markle, E. (1981). “Controversies in Science and Technology: A Protocol for Comparative Research.” Science, Technology and Human Values 5: 26–30.Google Scholar
President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (1980). “Splicing Genes: A Report on the Ethical and Social Implications of Genetic Engineering.” Draft. June 10.Google Scholar
Randall, C., Mandelbaum, B., and Kelly, T.(n.d.)Letter to President Carter.Google Scholar
Recombinant DNA Research (1985). Request for Public Comment on “Points to Consider in the Design and Submission of Human Somatic-Cell Gene Therapy Protocols.” Federal Register Tuesday, 50 (14): 2940–2945.Google Scholar
Roblin, R. (1972). “Gene Therapy via Transduction.” In Reich, W. T. (ed)., Encyclopedia of Bioethics. New York: MacMillon Publishing Co. Inc., p. 516.Google Scholar
Rogers, S., Lowenthal, A., Terheggen, H., and Columbo, J. P. (1973). “Induction of Arginase Activity with the Shope Papilloma Virus in Tissue Culture Cells from an Arginemic Patient.” J. Exper. Med. 137: 1091–1096.CrossRefGoogle ScholarPubMed
Salsar, W. (1981). Personal interview, April 11.Google Scholar
Schmeck, H. M. Jr. (1970). “Virus Is Injected into Two Children in Effort to Alter Chemical Trait.” The New York Times, September 21.Google Scholar
Schmeck, H. M. Jr. (1984). “Treatment is Nearing for Genetic Defects.” The New York Times, April 10.Google Scholar
Siegel, S. (1982). Testimony before the Investigation and Oversight Subcommittee, U. S. House of Representatives Committee on Science and Technology, November 17.Google Scholar
Sun, M. (1986). “Biotech Guidelines Challenged by Rifkin.” Science 233: 516.CrossRefGoogle ScholarPubMed
Talbot, B. (1981). “Report of the NIH Ad Hoc Committee on the UCLA Report Concerning Certain Research Activities of Dr. Martin J. Cline,” May 21.Google Scholar
U. S. House of Representatives (1982). Committee on Science and Technology, Subcommittee on Investigations and Oversight. “Human Genetic Engineering.” Congressional Record, November.Google Scholar
Wade, N. (1982). “UCLA Gene Therapy Racked by Friendly Fire.” Science 210: 590–592.Google Scholar
Watson, J. D. (1968). Double Helix. New York: Atheneum.Google Scholar
Watson, J. D., and Tooze, J. (1981). The DNA Story. San Francisco: W. H. Freeman and Co.Google Scholar